Literature DB >> 2272782

Hereditary motor and sensory neuropathy type I and type II.

A Sghirlanzoni1, D Pareyson, V Scaioli, R Marazzi, L Pacini.   

Abstract

In an attempt to clearly identify the different HMSN subgroups, we prospectively evaluated 128 subjects (46 index cases, 39 affected and 43 unaffected relatives) on clinical, genetic and electrophysiological grounds. The diagnosis of HMNS I or II was made in 77 patients. Differential diagnosis between type I and II patients was impossible on clinical grounds alone, but nerve conduction study showed a clear-cut subdivision into two populations. MCV behavior was consistent within families. Inheritance, autosomal dominant in almost all cases, was probably recessive in three HMSN I subjects and pedigree analysis pointed to X-linked transmission in one HMSN I family. We found no evidence for linkage to Duffy locus. We think that similar HMSN phenotypes can be determined by different gene defects. Ulnar nerve F-conduction velocity did not significantly differ from distal MCV in HMSN I: the evidence of a diffuse slowing of nerve conduction supports the hypothesis of a primary myelin defect.

Entities:  

Mesh:

Year:  1990        PMID: 2272782     DOI: 10.1007/bf02336567

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  17 in total

1.  Clinical and electrodiagnostic features of Charcot-Marie-Tooth syndrome.

Authors:  J C Brust; R E Lovelace; S Devi
Journal:  Acta Neurol Scand Suppl       Date:  1978

2.  Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography.

Authors:  F Buchthal; F Behse
Journal:  Brain       Date:  1977-03       Impact factor: 13.501

3.  X-linked neuropathy: gene localization with DNA probes.

Authors:  K H Fischbeck; N ar-Rushdi; M Pericak-Vance; M Rozear; A D Roses; J P Fryns
Journal:  Ann Neurol       Date:  1986-10       Impact factor: 10.422

4.  Hereditary motor and sensory polyneuropathy (peroneal muscular atrophy).

Authors:  P K Thomas; D B Calne; G Stewart
Journal:  Ann Hum Genet       Date:  1974-10       Impact factor: 1.670

5.  F-wave velocity in the central segment of the median and ulnar nerves. A study in normal subjects and in patients with Charcot-Marie-Tooth disease.

Authors:  J Kimura
Journal:  Neurology       Date:  1974-06       Impact factor: 9.910

6.  Nerve conduction studies in Charcot-Marie-Tooth disease.

Authors:  P M Humberstone
Journal:  Acta Neurol Scand       Date:  1972       Impact factor: 3.209

7.  Absence of genetic linkage of Charcot-Marie-Tooth disease (HMSN Ia) with chromosome 1 gene markers.

Authors:  P Raeymaekers; P De Jonghe; H Backhovens; A Wehnert; G De Winter; L Swerts; J Gheuens; J J Martin; A Vandenberghe; C Van Broeckhoven
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

8.  Longitudinal conduction studies in hereditary motor and sensory neuropathy type 1.

Authors:  E P Roy; L Gutmann; J E Riggs
Journal:  Muscle Nerve       Date:  1989-01       Impact factor: 3.217

9.  Peroneal muscular atrophy. Part 1. Clinical and electrophysiological study.

Authors:  P Bouché; R Gherardi; H P Cathala; F Lhermitte; P Castaigne
Journal:  J Neurol Sci       Date:  1983 Oct-Nov       Impact factor: 3.181

10.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

View more
  3 in total

Review 1.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

2.  Homozygous hypertrophic hereditary motor and sensory neuropathies.

Authors:  A Sghirlanzoni; D Pareyson; R Marazzi; G Cavaletti; E Bellone; P Mandich; M R Balestrini; D Riva
Journal:  Ital J Neurol Sci       Date:  1994-02

3.  F response and somatosensory and brainstem auditory evoked potential studies in HMSN type I and II.

Authors:  V Scaioli; D Pareyson; G Avanzini; A Sghirlanzoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.